Darrin R. Uecker is the CEO of Pulse Biosciences, Inc., a company he joined in September 2015. With a Master’s degree in Electrical and Computer Engineering from the University of California, Santa Barbara, he brings a solid technical background to...

Darrin R. Uecker is the CEO of Pulse Biosciences, Inc., a company he joined in September 2015. With a Master’s degree in Electrical and Computer Engineering from the University of California, Santa Barbara, he brings a solid technical background to the role. Under his leadership, Pulse Biosciences has focused on innovate medical products. Interestingly, Uecker has had a complex compensation structure, earning just under $1 million in total compensation in 2022 but facing challenges in meeting corporate objectives, leading to no cash bonuses. A notable part of his employment agreement included the right to stock options after the company’s IPO, although he postponed receipt of these options to allow for a more favorable plan approval. Uecker owns around 753,317 shares of the company, showing his substantial investment in its future. He has faced fluctuations in his compensation over the years, but his long-term commitment to Pulse Biosciences remains clear. Darrin Uecker represents a blend of technical expertise and executive leadership in the biotech field.